Hyperhomocysteinemia in ankylosing spondylitis: Prevalence and association with clinical variables

Rheumatology International

Volumn 28, Issue 12, 2008, Pages 1223-1228

  Gonzalez Lopez, Laura ^a   Sanchez Hernandez, Julia D ^a   Aguilar Chavez, Erika A G ^a   Cota Sanchez, Adolfo R ^b   Lopez Olivo, Maria A ^c   Villa Manzano, Alberto I ^a   Ortega Flores, Ricardo ^b   Espinoza Magaña, Genadia L ^a   Rojo Contreras, Wendoline ^d   Cardona Muñoz, Ernesto G ^b   Gamez Nava, Jorge I ^a,e  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSIDAD DE COLIMA   (Mexico)

^e Universidad de Colima ^*  (Mexico)

Author keywords

Ankylosing spondylitis; BASFI; Hyperhomocysteinemia; Prevalence

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MEXICO; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 51649102976     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0687-4     Document Type: Article

References (28)

1. CJ Boushey SAA Beresford GS Omenn AG Motulsky 1995 A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 274 1049 1057 10.1001/jama.274.13.1049
2. M Peters I van der Horst-Bruinsma B Dijkmans M Nurmohamed 2004 Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis Semin Arthritis Rheum 34 585 592 10.1016/j.semarthrit.2004.07.010
3. J Braun T Pincus 2002 Mortality, course of disease and prognosis of patients with ankylosing spondylitis Clin Exp Rheumatol 20 Suppl 28 S16 S22
4. JC Wei MS Jan CT Yu YC Huang CC Yang HK Tsou 2007 Plasma homocysteine status in patients with ankylosing spondylitis Clin Rheumatol 26 739 742 10.1007/s10067-006-0396-x
5. D Malesci A Niglio GA Mennillo G La Montagna 2007 High prevalence of metabolic syndrome in patients with ankylosing spondylitis Clin Rheumatol 26 710 714 10.1007/s10067-006-0380-5
6. XY Xu WH Zhou CS Xiao XF Li LY Wang 2005 A clinical study of hyperhomocysteinemia in rheumatological diseases Zhonghua Nei Ke Za Zhi 44 111 114
7. S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 361 368 10.1002/art.1780270401
8. S Garrett T Jenkinson LG Kennedy H Whitelock P Gaisford A Calin 1994 A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index J Rheumatol 21 2286 2291
9. A Calin S Garrett H Whitelock LG Kennedy J O'Hea P Mallorie 1994 A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index J Rheumatol 21 2281 2285
10. LH Daltroy MG Larson NW Roberts MH Liang 1990 A modification of the Health Assessment Questionnaire for the spondyloarthropathies J Rheumatol 17 946 950
11. MT Shipchandler EG Moore 1995 Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer Clin Chem 41 991 994
12. C Han DW Robinson Jr MV Hackett LC Paramore KH Fraeman M Bala 2006 Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis J Rheumatol 33 2167 2172
13. MA Lopez-Olivo L Gonzalez-Lopez A Garcia-Gonzalez AI Villa-Manzano AR Cota-Sanchez M Salazar-Paramo 2006 Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis Scand J Rheumatol 35 112 116 10.1080/03009740510026922
14. LM Joubert MM Manore 2006 Exercise, nutrition, and homocysteine Int J Sport Nutr Exerc Metab 16 341 361
15. S Wallberg-Jonsson JT Cvetkovic KG Sundqvist AK Lefvert S Rantapaa-Dahlqvist 2002 Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis J Rheumatol 29 875 882
16. K Schroecksnadel B Frick M Fiegl C Winkler HA Denz D Fuchs 2007 Hyperhomocysteinaemia and immune activation in patients with cancer Clin Chem Lab Med 45 47 53 10.1515/CCLM.2007.012
17. OK Jensen C Rassmussen F Mollerup PB Christensen H Hansen S Ekelub 2002 Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation J Rheumatol 29 1615 1618
18. N Hornung T Ellingsen K Stengaard-Pedersen JH Poulsen 2004 Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement J Rheumatol 31 2374 2381
19. CJ Haagsma HJ Blom PL van Riel MA van't Hof BA Giesendorf D Van Oppenraaij-Emmerzaal 1999 Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis Ann Rheum Dis 58 79 84
20. M Hoekstra CJ Haagsma CJ Doelman MA van de Laar 2005 Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate Ann Rheum Dis 64 141 143 10.1136/ard.2003.019828
21. M Medina JL Urdiales MI Amores-Sanchez 2001 Roles of homocysteine in cell metabolism: old and new functions Eur J Biochem 268 3871 3882 10.1046/j.1432-1327.2001.02278.x
22. AJ Lusis 2000 Atherosclerosis Nature 407 233 241 10.1038/35025203
23. S Voutilainen JD Morrow LJ Roberts 2nd G Alfthan H Alho K Nyyssonen JT Salonen 1999 Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels Arterioscler Thromb Vasc Biol 19 1263 1266
24. NP Dudman SE Temple XW Guo W Fu MA Perry 1999 Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo Circ Res 84 409 416
25. PH Whincup H Refsum IJ Perry R Morris M Walker L Lennon A Thomson PM Ueland SB Ebrahim 1999 Serum total homocysteine and coronary heart disease: prospective study in middle aged men Heart 82 448 454
26. JW Eikelboom E Lonn J Genest Jr G Hankey S Yusuf 1999 Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence Ann Intern Med 131 363 375
27. DS Wald M Law JK Morris 2002 Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 325 1202 10.1136/bmj.325.7374. 1202
28. AG Bostom H Silbershatz IH Rosenberg J Selhub RB D'Agostino PA Wolf PF Jacques PW Wilson 1999 Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women Arch Intern Med 159 1077 1080 10.1001/archinte.159.10.1077